Anish Bhatnagar
Company: Soleno Therapeutics
Job title: Chief Executive Officer
Seminars:
Live Q&A Session with Your Expert Speakers 5:50 pm
day: Day Two
Exploring DCCR as an Important Therapeutic Option for PWS 5:20 pm
Elucidating the mechanism of action for the DCCR development program for PWS Evaluating the dose rationale for future studies Regulatory back and forth for advancing phase 3 program, outcomes and key learningsRead more
day: Day Two